Aug 17, 2014 11:24 PM EDT
FDA Approves New MS Treatment: Plegridy
The U.S. Food and Drug Administration (FDA) has approved a new treatment for the illness known as Plegridy through Biogen Idec Inc (BIIB), a company that specializes in developing drugs for neuro-degenerative diseases, autoimmune diseases, and hemophilia.